Citation: De. Kandzari et Pj. Goldschmidt-clermont, Platelet polymorphisms and ischemic heart disease: Moving beyond traditional risk factors, J AM COL C, 38(4), 2001, pp. 1028-1032
Authors:
Kandzari, DE
Lam, LC
Eisenstein, EL
Clapp-Channing, N
Fine, JT
Califf, RM
Mark, DB
Jollis, JG
Citation: De. Kandzari et al., Advanced coronary artery disease: Appropriate end points for trials of novel therapies, AM HEART J, 142(5), 2001, pp. 843-851
Authors:
Kandzari, DE
Warner, JJ
O'Laughlin, MP
Harrison, JK
Citation: De. Kandzari et al., Percutaneous stenting of right pulmonary artery stenosis in fibrosing mediastinitis, CATHET C IN, 49(3), 2000, pp. 321-324
Authors:
Kandzari, DE
Tcheng, JE
Harrington, RA
Sketch, MH
Citation: De. Kandzari et al., "Rescue"' platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: Bailing out of a sunken ship, J INVAS CAR, 12(10), 2000, pp. 502-504
Authors:
McGuire, DK
O'Shea, JC
Dyke, CK
Kandzari, DE
East, MA
Tolleson, TR
Citation: Dk. Mcguire et al., Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000, AM HEART J, 140(1), 2000, pp. 181-188
Citation: De. Kandzari et P. Goldschmidt-clermont, Coronary events with lipid-lowering therapy: The AFCAPS/TexCAPS trial, J AM MED A, 281(5), 1999, pp. 415-415